1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Montserret, R.
Penin, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
1083-351X
10.1074/jbc.M803981200
18644781
Structural and functional characterization of non-structural protein 2 for its role in hepatitis C virus assembly
2008
10.2210/pdb2jy0/pdb
pdb_00002jy0
2837.341
Protease NS2-3
membrane segment, residues 1-27
C9A
1
syn
polymer
no
no
MDREMAASAGGAVFVGLVLLTLSPHYK
MDREMAASAGGAVFVGLVLLTLSPHYK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
database_2
struct_ref_seq_dif
repository
Initial release
Version format compliance
Data collection
Database references
Derived calculations
Other
Database references
1
0
2008-09-16
1
1
2011-07-13
1
2
2020-02-26
1
3
2021-11-10
_pdbx_database_status.status_code_cs
_pdbx_nmr_software.name
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
BMRB
Y
PDBJ
2007-12-04
REL
REL
REL
synthetic peptide
sample
THIS SEQUNECE COME FROM A NATURAL VARIANT OF HCV STRAIN CON1.
structures with the least restraint violations
50
40
2D 1H-1H NOESY
2D 1H-1H TOCSY
2D 1H-13C HSQC
2D 1H-1H NOESY
2D 1H-1H TOCSY
2D 1H-13C HSQC
0.9
mM
ambient
298
K
ambient
308
K
DGSA-distance geometry simulated annealing
1
closest to the average
0.9mM NS2(1-27), trifluoroethanol/water
trifluoroethanol/water
Varian
collection
VNMR
Varian
processing
VNMR
Goddard
chemical shift assignment
Sparky
Goddard
peak picking
Sparky
Goddard
data analysis
Sparky
Schwieters, Kuszewski, Tjandra and Clore
structure solution
X-PLOR NIH
Schwieters, Kuszewski, Tjandra and Clore
refinement
X-PLOR NIH
500
Varian
UNITYPLUS
Varian UnityPlus
MET
1
n
1
MET
1
A
ASP
2
n
2
ASP
2
A
ARG
3
n
3
ARG
3
A
GLU
4
n
4
GLU
4
A
MET
5
n
5
MET
5
A
ALA
6
n
6
ALA
6
A
ALA
7
n
7
ALA
7
A
SER
8
n
8
SER
8
A
ALA
9
n
9
ALA
9
A
GLY
10
n
10
GLY
10
A
GLY
11
n
11
GLY
11
A
ALA
12
n
12
ALA
12
A
VAL
13
n
13
VAL
13
A
PHE
14
n
14
PHE
14
A
VAL
15
n
15
VAL
15
A
GLY
16
n
16
GLY
16
A
LEU
17
n
17
LEU
17
A
VAL
18
n
18
VAL
18
A
LEU
19
n
19
LEU
19
A
LEU
20
n
20
LEU
20
A
THR
21
n
21
THR
21
A
LEU
22
n
22
LEU
22
A
SER
23
n
23
SER
23
A
PRO
24
n
24
PRO
24
A
HIS
25
n
25
HIS
25
A
TYR
26
n
26
TYR
26
A
LYS
27
n
27
LYS
27
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
3
0.271
SIDE CHAIN
2
A
ARG
3
0.287
SIDE CHAIN
3
A
ARG
3
0.289
SIDE CHAIN
4
A
ARG
3
0.316
SIDE CHAIN
5
A
ARG
3
0.309
SIDE CHAIN
6
A
ARG
3
0.283
SIDE CHAIN
7
A
ARG
3
0.316
SIDE CHAIN
8
A
ARG
3
0.314
SIDE CHAIN
9
A
ARG
3
0.315
SIDE CHAIN
10
A
ARG
3
0.316
SIDE CHAIN
11
A
ARG
3
0.314
SIDE CHAIN
12
A
ARG
3
0.316
SIDE CHAIN
13
A
ARG
3
0.290
SIDE CHAIN
14
A
ARG
3
0.306
SIDE CHAIN
15
A
ARG
3
0.317
SIDE CHAIN
16
A
ARG
3
0.317
SIDE CHAIN
17
A
ARG
3
0.318
SIDE CHAIN
18
A
ARG
3
0.301
SIDE CHAIN
19
A
ARG
3
0.316
SIDE CHAIN
20
A
ARG
3
0.308
SIDE CHAIN
21
A
ARG
3
0.312
SIDE CHAIN
22
A
ARG
3
0.316
SIDE CHAIN
23
A
ARG
3
0.317
SIDE CHAIN
24
A
ARG
3
0.301
SIDE CHAIN
25
A
ARG
3
0.310
SIDE CHAIN
26
A
ARG
3
0.316
SIDE CHAIN
27
A
ARG
3
0.281
SIDE CHAIN
28
A
ARG
3
0.318
SIDE CHAIN
29
A
ARG
3
0.305
SIDE CHAIN
30
A
ARG
3
0.298
SIDE CHAIN
31
A
ARG
3
0.310
SIDE CHAIN
32
A
ARG
3
0.316
SIDE CHAIN
33
A
ARG
3
0.317
SIDE CHAIN
34
A
ARG
3
0.317
SIDE CHAIN
35
A
ARG
3
0.311
SIDE CHAIN
36
A
ARG
3
0.313
SIDE CHAIN
37
A
ARG
3
0.288
SIDE CHAIN
38
A
ARG
3
0.317
SIDE CHAIN
39
A
ARG
3
0.309
SIDE CHAIN
40
A
ARG
3
0.309
SIDE CHAIN
1
A
ARG
3
60.29
71.46
1
A
HIS
25
55.04
71.52
2
A
ARG
3
-161.37
53.76
2
A
MET
5
-132.77
-57.52
2
A
ALA
7
-139.72
-44.58
2
A
SER
8
-69.98
86.46
2
A
ALA
9
-175.65
-63.27
2
A
SER
23
63.84
104.84
3
A
ASP
2
59.37
-164.50
3
A
ARG
3
-124.38
-74.23
4
A
ASP
2
-163.18
-59.61
4
A
MET
5
-165.54
-42.19
5
A
ARG
3
-156.51
55.03
5
A
MET
5
-166.40
-62.30
5
A
SER
8
-159.02
-84.72
6
A
MET
5
-168.87
-60.97
6
A
ALA
9
-150.60
-45.14
6
A
SER
23
64.23
68.35
6
A
HIS
25
-136.05
-51.25
6
A
TYR
26
57.92
75.30
7
A
ASP
2
-131.63
-58.58
7
A
ARG
3
64.45
-79.84
7
A
ALA
9
-146.88
-64.74
7
A
HIS
25
-113.31
53.22
8
A
ASP
2
-103.64
-167.17
8
A
MET
5
-171.71
-35.06
8
A
ALA
7
-161.03
31.28
8
A
SER
23
67.36
150.45
9
A
HIS
25
-104.87
51.51
10
A
ASP
2
-155.16
-45.87
10
A
ARG
3
60.69
69.21
10
A
MET
5
-120.80
-70.73
10
A
ALA
7
63.92
100.21
11
A
MET
5
-88.26
-73.85
11
A
ALA
6
56.67
18.51
11
A
LEU
22
-119.81
-78.73
12
A
GLU
4
57.99
19.06
12
A
SER
23
55.17
93.59
13
A
ASP
2
65.18
-76.36
13
A
GLU
4
-158.06
-59.01
13
A
ALA
9
74.76
-52.36
13
A
SER
23
61.68
99.88
14
A
MET
5
-139.06
-64.58
14
A
LEU
22
-118.57
50.55
15
A
ARG
3
-90.99
-90.16
15
A
ALA
9
65.42
-73.16
15
A
SER
23
62.09
90.90
15
A
HIS
25
-129.65
-65.75
16
A
MET
5
-171.78
-45.77
16
A
ALA
6
-92.15
43.85
17
A
ASP
2
-156.52
-60.85
17
A
GLU
4
-93.82
-60.33
17
A
SER
8
59.74
-162.46
17
A
ALA
9
-87.99
39.82
17
A
LEU
22
-64.34
-75.27
17
A
SER
23
54.91
-172.55
18
A
ASP
2
66.66
-65.65
18
A
SER
23
62.36
73.69
18
A
TYR
26
61.16
-168.19
19
A
ASP
2
-133.38
-54.82
19
A
ALA
9
39.75
83.82
19
A
ALA
12
75.45
-47.96
19
A
LEU
22
-102.08
62.35
19
A
SER
23
-117.07
78.07
20
A
ALA
6
-96.70
-66.90
20
A
ALA
7
-150.79
21.37
20
A
SER
23
68.67
167.24
21
A
ALA
12
75.48
-48.44
21
A
TYR
26
-103.93
70.20
22
A
ARG
3
58.88
-94.61
22
A
GLU
4
55.67
18.34
22
A
MET
5
-171.79
-60.43
22
A
ALA
7
-152.20
-76.64
22
A
SER
8
57.33
-76.62
22
A
VAL
13
-142.56
-60.56
22
A
SER
23
-165.90
95.11
23
A
ALA
9
-139.09
-60.91
23
A
TYR
26
59.12
79.65
24
A
GLU
4
-137.66
-45.69
24
A
SER
8
54.05
-164.64
24
A
ALA
12
73.80
-46.49
25
A
GLU
4
-137.83
-63.94
25
A
SER
8
-98.73
47.52
25
A
ALA
12
59.36
14.68
25
A
VAL
13
-128.29
-58.07
25
A
SER
23
61.76
96.86
26
A
ARG
3
-160.47
43.29
26
A
GLU
4
-132.26
-58.03
26
A
ALA
7
-88.41
-99.81
26
A
SER
8
54.54
17.68
26
A
SER
23
69.20
130.51
27
A
ASP
2
-135.55
-57.38
27
A
ARG
3
-138.89
-135.84
27
A
GLU
4
60.22
75.60
27
A
ALA
9
-154.83
-65.99
27
A
SER
23
67.88
163.04
28
A
MET
5
-148.97
37.65
28
A
VAL
13
-139.81
-57.46
28
A
SER
23
-152.10
77.66
30
A
ASP
2
61.57
107.84
30
A
ALA
7
-167.48
80.07
30
A
ALA
9
66.53
-69.35
31
A
ARG
3
58.13
19.33
31
A
VAL
13
-126.65
-56.50
31
A
SER
23
56.83
70.19
32
A
ASP
2
-157.21
-87.61
32
A
ALA
12
-162.28
-59.09
32
A
LEU
22
-102.25
48.19
32
A
SER
23
62.09
100.60
32
A
HIS
25
-144.20
41.15
33
A
ARG
3
-161.72
-103.25
33
A
MET
5
-168.53
-45.84
33
A
ALA
9
-78.87
47.45
33
A
PRO
24
-69.55
93.01
34
A
ASP
2
62.74
170.69
34
A
ARG
3
-135.73
-52.56
34
A
SER
23
70.14
160.78
35
A
GLU
4
-145.32
-76.32
35
A
ALA
9
-95.54
56.59
35
A
ALA
12
-168.46
-60.31
35
A
SER
23
-160.56
109.71
35
A
HIS
25
-107.71
49.38
36
A
ALA
12
-164.39
-54.85
36
A
LEU
22
63.68
83.72
36
A
TYR
26
-114.30
59.59
37
A
ALA
7
58.98
89.04
37
A
ALA
12
-154.26
-57.22
37
A
HIS
25
-162.46
77.57
38
A
ALA
7
52.90
83.90
38
A
ALA
9
-94.91
59.03
38
A
HIS
25
-152.07
42.30
39
A
ARG
3
-119.19
-168.06
39
A
MET
5
53.52
75.51
39
A
ALA
6
-95.70
39.25
39
A
ALA
7
55.21
96.74
39
A
VAL
13
-143.37
-58.27
39
A
LEU
22
-106.16
47.60
40
A
ASP
2
57.06
-139.38
40
A
ARG
3
-76.77
-135.70
40
A
MET
5
-146.99
16.47
40
A
ALA
12
-168.91
-59.19
40
A
PRO
24
-69.79
73.32
40
A
HIS
25
-127.65
-56.42
Solution NMR structure of HCV NS2 protein, membrane segment (1-27)
1
N
N
A
ARG
3
A
ARG
3
HELX_P
A
SER
8
A
SER
8
1
1
6
A
GLY
11
A
GLY
11
HELX_P
A
SER
23
A
SER
23
1
2
13
MEMBRANE PROTEIN, VIRAL PROTEIN
membrane segment, HCV NS2 protein, MEMBRANE PROTEIN, VIRAL PROTEIN
POLG_HCVCO
UNP
1
810
Q9WMX2
MDREMAASCGGAVFVGLILLTLSPHYK
810
836
2JY0
1
27
Q9WMX2
A
1
1
27
1
CYS
engineered mutation
ALA
9
2JY0
A
Q9WMX2
UNP
818
9
1
ILE
SEE REMARK 999
VAL
18
2JY0
A
Q9WMX2
UNP
827
18